A novel, integrated approach for understanding and investigating Healthcare Associated Infections: A risk factors constellation analysis.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
04
04
2022
accepted:
06
02
2023
medline:
28
3
2023
entrez:
24
3
2023
pubmed:
25
3
2023
Statut:
epublish
Résumé
Healthcare-associated infections (HAIs) and antimicrobial resistance (AMR) are major public health threats in upper- and lower-middle-income countries. Electronic health records (EHRs) are an invaluable source of data for achieving different goals, including the early detection of HAIs and AMR clusters within healthcare settings; evaluation of attributable incidence, mortality, and disability-adjusted life years (DALYs); and implementation of governance policies. In Italy, the burden of HAIs is estimated to be 702.53 DALYs per 100,000 population, which has the same magnitude as the burden of ischemic heart disease. However, data in EHRs are usually not homogeneous, not properly linked and engineered, or not easily compared with other data. Moreover, without a proper epidemiological approach, the relevant information may not be detected. In this retrospective observational study, we established and engineered a new management system on the basis of the integration of microbiology laboratory data from the university hospital "Policlinico Tor Vergata" (PTV) in Italy with hospital discharge forms (HDFs) and clinical record data. All data are currently available in separate EHRs. We propose an original approach for monitoring alert microorganisms and for consequently estimating HAIs for the entire period of 2018. Data extraction was performed by analyzing HDFs in the databases of the Hospital Information System. Data were compiled using the AREAS-ADT information system and ICD-9-CM codes. Quantitative and qualitative variables and diagnostic-related groups were produced by processing the resulting integrated databases. The results of research requests for HAI microorganisms and AMR profiles sent by the departments of PTV from 01/01/2018 to 31/12/2018 and the date of collection were extracted from the database of the Complex Operational Unit of Microbiology and then integrated. We were able to provide a complete and richly detailed profile of the estimated HAIs and to correlate them with the information contained in the HDFs and those available from the microbiology laboratory. We also identified the infection profile of the investigated hospital and estimated the distribution of coinfections by two or more microorganisms of concern. Our data were consistent with those in the literature, particularly the increase in mortality, length of stay, and risk of death associated with infections with Staphylococcus spp, Pseudomonas aeruginosa, Klebsiella pneumoniae, Clostridioides difficile, Candida spp., and Acinetobacter baumannii. Even though less than 10% of the detected HAIs showed at least one infection caused by an antimicrobial resistant bacterium, the contribution of AMR to the overall risk of increased mortality was extremely high. The increasing availability of health data stored in EHRs represents a unique opportunity for the accurate identification of any factor that contributes to the diffusion of HAIs and AMR and for the prompt implementation of effective corrective measures. That said, artificial intelligence might be the future of health data analysis because it may allow for the early identification of patients who are more exposed to the risk of HAIs and for a more efficient monitoring of HAI sources and outbreaks. However, challenges concerning codification, integration, and standardization of health data recording and analysis still need to be addressed.
Identifiants
pubmed: 36961857
doi: 10.1371/journal.pone.0282019
pii: PONE-D-22-06215
pmc: PMC10038248
doi:
Substances chimiques
Anti-Infective Agents
0
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0282019Informations de copyright
Copyright: © 2023 Carestia et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Drug Healthc Patient Saf. 2020 Oct 14;12:177-185
pubmed: 33116913
J Hosp Infect. 2021 Jul;113:164-171
pubmed: 33940090
Risk Manag Healthc Policy. 2020 Sep 28;13:1765-1780
pubmed: 33061710
Acta Biomed. 2018 Jun 07;89(2):302-314
pubmed: 29957768
PLoS One. 2020 May 21;15(5):e0233329
pubmed: 32437377
J Hosp Infect. 2021 Aug;114:10-22
pubmed: 34301392
Lancet Microbe. 2021 Apr;2(4):e135-e136
pubmed: 33655229
Gastrointest Endosc Clin N Am. 2020 Oct;30(4):637-652
pubmed: 32891222
Int Orthop. 2021 Dec;45(12):3201-3209
pubmed: 34350473
Crit Care Med. 2021 Feb 1;49(2):169-187
pubmed: 33438970
Plast Reconstr Surg. 2022 Apr 1;149(4):617e-628e
pubmed: 35103626
J Infect Prev. 2015 Sep;16(5):208-214
pubmed: 28989432
Euro Surveill. 2018 Nov;23(46):
pubmed: 30458912
Curr Opin Crit Care. 2020 Oct;26(5):433-441
pubmed: 32739970
Clin Infect Dis. 2018 Jun 1;66(12):1940-1947
pubmed: 29444225
Crit Care Med. 2018 Jul;46(7):1093-1098
pubmed: 29642107
Int J Environ Res Public Health. 2021 May 17;18(10):
pubmed: 34067797
J Am Med Inform Assoc. 2014 Sep-Oct;21(5):942-51
pubmed: 24421290
Antibiotics (Basel). 2022 Jan 21;11(2):
pubmed: 35203743
Lancet Public Health. 2019 Dec;4(12):e645-e657
pubmed: 31759893
Epidemiol Infect. 2011 Sep;139(9):1326-31
pubmed: 21087536
Clin Microbiol Infect. 2021 Dec;27(12):1772-1776
pubmed: 34111586
PLoS Med. 2016 Oct 18;13(10):e1002150
pubmed: 27755545
J Prev Med Hyg. 2022 Jul 31;63(2):E304-E309
pubmed: 35968075